Preview

Медицинский Совет

Расширенный поиск

ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ У ПАЦИЕНТОВ С ГЕМОРРАГИЧЕСКИМ ИНСУЛЬТОМ: ПОДХОДЫ К АНТИКОАГУЛЯНТНОЙ ТЕРАПИИ

https://doi.org/10.21518/2079-701X-2017-10-6-11

Полный текст:

Аннотация

Фибрилляция предсердий (ФП) – наиболее распространенное нарушение ритма сердца. ФП ассоциируется  с увеличением частоты госпитализаций, смертности, развития инсульта, сердечной недостаточности. Основой профилактики сердечно-сосудистых осложнений у больных ФП являются пероральные антикоагулянты. Однако использование антикоагулянтов повышает риск развития внутримозговых гематом. Особую группу больных, перенесших геморрагический инсульт, составляют пациенты с ФП. Данной категории больных, с одной стороны, показана антикоагулянтная терапия в связи с высоким риском развития тромбоэмболических  осложнений, с другой стороны, она противопоказана в связи с развитием геморрагического  инсульта. Оптимальный  режим  антитромботической терапии  до  конца  остается  неизвестным. Обсуждаются современные подходы к терапии ФП у больных, перенесших геморрагический инсульт.

Об авторах

А. М. Кулагина
Национальный медико-хирургический центр им. Н.И. Пирогова
Россия

Москва



А. В. Зорина
Национальный медико-хирургический центр им. Н.И. Пирогова
Россия

Москва



О. И. Виноградов
Национальный медико-хирургический центр им. Н.И. Пирогова
Россия

Доктор медиинских наук.

Москва




Список литературы

1. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/ Paisley study. Heart, 2001, 86: 516-521.

2. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA, 2001, 285: 2370-2375.

3. Kirchhof P, Auricchio A, Bax J et al. Outcome parameters for trials in atrial fibrillation: executive summary. Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). Eur Heart J, 2007, 28: 2803–2817.

4. Lip GY, Golding DJ, Nazir M et al. A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract, 1997, 47: 285–289.

5. Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation, 2006, 114: 119-125.

6. Heeringa J, van der Kuip DA, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J, 2006, 27: 949–953.

7. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibril-lation and flutter in the United States. Am J Cardiol, 2009, 104: 1534–1539.

8. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation, 2004, 110: 1042–1046.

9. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/ Paisley study. Am J Med, 2002, 113: 359–364.

10. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J, 2010, 31: 967–975.

11. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khoury J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke, 1997, 28: 1–5.

12. Fan JS, Huang HH, Chen YC, Yen DH, Kao WF, Huang MS, Huang CI, Lee CH. Emergency department neurologic deterioration in patients with spontaneous intracerebral hemorrhage: incidence, predictors, and prognostic significance. Acad Emerg Med, 2012, 19: 133–138. doi: 10.1111/j.1553-2712.2011.01285.

13. Arima H, Tzourio C, Butcher K, Anderson C, Bousser MG, Lees KR, Reid JL, Omae T, Woodward M, MacMahon S, Chalmers J, PROGRESS Collaborative Group. Prior events predict cerebrovascular and coronary outcomes in the trial. Stroke, 2006, 37: 1497–1502.

14. Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Longterm prognosis after recovery from primary intracerebral hemorrhage. Neurology, 2002, 59: 205–209.

15. Hanger HC, Wilkinson TJ, Fayez-Iskander N, Sainsbury R. The risk of recurrent stroke after intracerebral haemorrhage. J Neurol Neurosurg Psychiatry, 2007, 78: 836–840. doi: 10.1136/jnnp.2006.106500.

16. Bounds JV, Wiebers DO, Whisnant JP & Okazaki H (). Mechanisms and timing of deaths from cerebral infarction. Stroke, 1981, 12(4): 474-477.

17. Muir KW, Watt A, Baxter G, Grosset DG, Lees KR. Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute stroke. QJM: monthly journal of the Association of Physicians, 2000, 93: 35964.

18. Dennis M, Sandercock PA, Reid J, et al. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial. Lancet, 2009, 373: 1958-65.

19. Lacut K, Bressollette L, Le Gal G, Etienne E, De Tinteniac A, Renault A, et al. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage. Neurology, 2005, 65: 865-9.

20. Borow M, Goldson H. Postoperative venous thrombosis. Evaluation of five methods of treatment. Am J Surg, 1981, 141: 245-51.

21. Sabri S, Roberts VC, Cotton LT. Prevention of early postoperative deep vein thrombosis by intermittent compression of the leg during surgery. Br Med J, 1971, 4: 394-6.

22. Hills NH, Pflug JJ, Jeyasingh K, Boardman L, Calnan JS. Prevention of deep vein thrombosis by intermittent pneumatic compression of calf. Br Med J, 1972, 1: 131-5.

23. Roberts VC, Cotton LT. Prevention of postoperative deep vein thrombosis in patients with malignant disease. Br Med J, 1974, 1: 358-60.

24. Clark WB, MacGregor AB, Prescott RJ, Ruckley CV. Pneumatic compression of the calf and postoperative deep-vein thrombosis. Lancet, 1974, 2: 5-7.

25. Turpie AG, Gallus A, Beattie WS, Hirsh J. Prevention of venous thrombosis in patients with intracranial disease by intermittent pneumatic compression of the calf. Neurology, 1977 27: 435-8.

26. Coe NP, Collins RE, Klein LA, Bettmann MA, Skillman JJ, Shapiro RM et al. Prevention ofdeep vein thrombosis in urological patients: a controlled, randomized trial of low-dose heparin and external pneumatic compression boots. Surgery, 1978, 83: 230-4.

27. Skillman JJ, Collins RE, Coe NP, Goldstein BS, Shapiro RM, Zervas NT et al. Prevention of deep vein thrombosis in neurosurgical patients: a controlled, randomized trial of external pneumatic compression boots. Surgery, 1978, 83: 354-8.

28. Turpie AG, Delmore T, Hirsh J, Hull R, Genton E, Hiscoe C et al. Prevention of venous thrombosis by intermittent sequential calf compression in patients with intracranial disease. Thromb Res, 1979, 15: 611-6.

29. Butson AR. Intermittent pneumatic calf compression for prevention of deep venous thrombosis in general abdominal surgery. Am J Surg, 1981, 142: 525-7.

30. Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creasman WT. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol, 1984, 63: 92-8.

31. Boeer A, Voth E, Henze T, Prange HW. Early heparin therapy in patients with spontaneous intracerebral haemorrhage. Journal of neurology, neurosurgery, and psychiatry, 1991, 54: 466-7.

32. Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, Mayberg M, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M, Broderick J, Connolly S, Feldmann E, Hanley D, Kase C, Krieger D, M. Mayberg, Morgenstern L, Ogilvy CS, Vespa P, Zuccarello M. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/ American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke, 2007, 38(6): 1-23.

33. Hemphill JC, Greenberg SM, Anderson CS, Becker K еt al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2015.

34. Hart RG. Metaanalysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med, 2007 Jun, 19, 146(12): 857-67.

35. Ruff CT. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A metaanalysis of ran domised trials. Lancet, 2014 Mar, 15, 383(9921): 955-62. doi: 10.1016/S0140-6736(13)62343-0. Epub 2013 Dec 4.

36. Chiang CE. Stroke prevention in atrial fibrillation: an Asian perspective. Thromb Haemost, 2014 May, 111(5): 789-97. doi: 10.1160/TH13-11-0948. Epub 2014 Feb 6.

37. Radberg JA. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke, 1991 May, 22(5): 571-6.

38. Granger CB. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med, 2011 Sep, 15, 365(11): 981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

39. Chan NC. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions. Thromb Haemost., 2014 May 5, 111(5): 798-807. doi: 10.1160/TH13-11-0918. Epub 2014 Feb 20.

40. Hankey GJ. Intracranial hemorrhage and novel anticoagulants for atrial fibrillation: what have we learned? Curr Cardiol Rep, 2014 May, 16(5): 480. doi: 10.1007/s11886-014-0480-9.

41. Nielsen PB. Restarting anticoagulant treatment after intracranial haemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality and bleeding: a Nationwide Cohort Study. Circulation, 2015, Aug 11, 132(6): 517-25.doi: 10.1161/ CIRCULATIONAHA.115.015735. Epub 2015 Jun 9.

42. Friberg L. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J, 2012 Jun, 33(12): 1500-10. doi: 10.1093/eurheartj/ehr488. Epub 2012 Jan 13.

43. Nielsen PB. Intracranial haemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: A nationwide cohort study. Chest, 2015, Jun, 147(6): 1651-8. doi: 10.1378/chest.14-2099.

44. Flynn R. Systematic review of observational research studying the long-term use of antithrombotic medicines following intracerebral hemorrhage. Cardiovasc Ther, 2010 Jun, 28(3): 177-84. doi: 10.1111/j.1755-5922.2009.00118.x. Epub 2010 Mar 7.

45. Flynn R. Antithrombotic medicines following intracerebral haemorrhage: where’s the evidence? Ther Adv Drug Saf, 2011 Oct, 2(5): 205-11. doi: 10.1177/2042098611415457.

46. Majeed A. Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke, 2010 Dec, 41(12): 2860-6. doi: 10.1161/STROKEAHA 110.593087. Epub 2010 Oct 28.

47. Marsh EB. Brain hemorrhage: restarting anticoagulation after intracranial hemorrhage. Nat Rev Neurol, 2011 Mar, 7(3): 130-2. doi: 10.1038/nrneurol.2011.6.Epub 2011 Feb 8.

48. Hankey GJ. Management of acute stroke in patients taking novel oral anticoagulants. Int J. Stroke, 2014 Jul, 9(5): 627-32. doi: 10.1111/ijs.12295. Epub 2014 Jun 2.

49. Hemphill JC. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke, 2015, Jul, 46(7): 2032-60. doi: 10.1161/STR.0000000000000069. Epub 2015 May 28.

50. Heidbuchel H. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non valvular atrial fibrillation. Europace, 2015 Oct, 17(10): 1467-507. doi: 10.1093/europace/euv309. Epub 2015 Aug 31.

51. Lip GY, Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke, 2010 Dec, 41(12): 2731-8. doi: 10.1161/STROKEAHA.110.590257 Epub 2010 Oct 21.

52. Ntaois G. CHADS2, CHA2DS2-VASc, and longterm stroke outcome in patients without atrial fibrillation. Neurology, 2013 Mar 12, 80(11): 1009-17.doi: 10.1212/WNL.0b013e318287281b. Epub 2013 Feb 13.


Просмотров: 187


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)